In a pan-cancer analysis using mRNA quantitative sequencing data, however, differing correlations between PLK1 upregulation and overall survival of patients suffering from different cancer entities have been shown with PLK1 overexpression not influencing overall survival for ovarian cancer (reviewed by [149]). The gene discussed is PLK1; the disease is ovarian cancer.